AEON Biopharma, Inc.

Q2 2024 13F Holders

Symbol
AEON
CUSIP
00791X100
Type
Equity
Class
CL A
Num filings
28
Total reported value, excl. options
$8.73 M
Manager Report Date Value ($000) Shares Option Type